Literature DB >> 16324236

Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.

Jan Roth1, Jirí Klempìi, Robert Jech, Jana Zidovská, Tereza Uhrová, Pavel Doubek, Olga Ulmanová, Hana Brozová, Markéta Volfová, Tereza Serranová, Evzen Ruzicka.   

Abstract

We analysed clinical data in 80 genetically confirmed Huntington?s disease (HD) patients and measured the severity of the head of the caudate nucleus (HCN) atrophy using computed tomography-guided planimetry. The results were compared with measurements obtained in 43 age-matched healthy subjects. Mean planimetric measurements of the HCN differed significantly between the HD patients and healthy controls (p<0.001). We observed a significant inverse correlation between duration of HD and HCN planimetric values (p<0.001). Physiological atrophy of the HCN with age was also present in healthy controls, but did not overlap with values obtained in HD patients (p<0.01). Furthermore, we found in our patients a statistically significant inverse correlation between the number of CAG triplet repeats and the age at onset of HD (p<0.001). Neither the number of CAG triplet repeats, nor the age at onset of HD was found to be related to the character of the initial clinical symptoms (motor vs mental). Similarly, no relationship emerged between maternal or paternal inheritance and the number of CAG triplet repeats. Moreover, the type of inheritance did not influence the age at onset of HD in our patients. Planimetric measurement of the HCN appears to be a simple and useful paraclinical tool for the diagnosis of HD.

Entities:  

Mesh:

Year:  2005        PMID: 16324236

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  2 in total

1.  Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression.

Authors:  Amy E Jolly; Vanessa Raymont; James H Cole; Alex Whittington; Gregory Scott; Sara De Simoni; Graham Searle; Roger N Gunn; David J Sharp
Journal:  Neuroimage Clin       Date:  2019-07-22       Impact factor: 4.881

2.  Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington's disease: a 12-month longitudinal study.

Authors:  Eng A Toh; Michael R MacAskill; John C Dalrymple-Alford; Daniel J Myall; Leslie Livingston; Sandy Ad Macleod; Tim J Anderson
Journal:  Transl Neurodegener       Date:  2014-07-12       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.